Natural killer (NK) cells gain functionality through an educational process ("licensing") that depends on killer immunoglobulin-like receptor (KIR) recognition of self-HLA class I molecules. In allogenic double umbilical cord blood stem cell transplantation (2CBT) the respective roles of the two cord blood (CB) units and recipient's HLA class I molecules in NK-cell licensing of the dominant CB (DCB) unit have yet to be characterized.
In this study, after 2CBT, NK cells from the DCB unit were found to be licensed by their own HLA class I molecules (HLA-C1/C2 allotypes). HLA molecules from the recipient and the non-dominant CB (ndCB) did not show a significant role.
In allogenic hematopoietic stem cell transplantation (allo-HSCT), NK cells are able to recognize and eliminate leukemic cells Recognition of self MHC-I molecules by inhibitory KIRs is involved in the calibration of the NK cell effector capacities during differentiation and maturation. This enables cells lacking MHC-I to be subsequently recognized as a "missing self" target 4 . We have shown that after KIR-ligand-mismatched conventional allo-HSCT in humans, the NK-cell licensing reiterates the responsiveness pattern determined by the donor's HLA ligands 5 . Two retrospective studies of the effect of KIR-ligand incompatibility in single 6, 7 and double 7 unrelated CB transplantation for hematological malignancies showed conflicting results in terms of leukemia-free survival and incidence of relapse. Usually, one CB unit dominates the other in the 2CBT. It is presumed that alloreactive graft-versus-graft rejection occurs, depending on the status of CD4 + T cells 8 or CD8 + T cells 9 . The dose of CD34 + cells 10 and the cell banking procedures 11 may also influence CB unit dominance which appears to be independent of the raises the issue of the NK-cell education. The objective of this study was to assess ex vivo NK-cell licensing after 2CBT in humans, without studying in vivo graft versus leukemia effect. This study focused on KIR2DL1/S1 and 2DL2/L3/S2 receptor function that recognize C2/C1 HLA-C allotypes.
This study included 20 patients having received a non-manipulated 2CBT to treat a hematological disorder (patients and transplant characteristics are summarized in Table S1 ; methods in supplemental methods Figure S1 ).
The NK-cell populations were analyzed for degranulation activity (CD107a is mobilized to cell surface following a co-culture with the K562 cell line) at 3, 6 and 12 months post-2CBT.
As a baseline measurement, we evaluated the degranulation of CD56 dim NKG2A -mono-KIR cells lacking a cognate HLA-C ligand in the two CB units and the recipient. Accordingly,
+ and CD56 dim NKG2A -KIR2DL2/L3/S2 + NK cells were unlicensed in the absence of HLA-C2 and HLA-C1 ligands respectively (degranulation's mean ± SD after K562 challenge: 3.1%±3.3;). As expected, CD56 dim NKG2A -KIR -NK cells responded also poorly during the first year post-2CBT ( Figure 1A ). At the opposite, the CD56 dim NKG2A + panKIR + NK subset was the most responsive (degranulation's mean:
28.1%±8.8) independently from the KIR/KIR ligand status of the recipient and CB units. We examined NK cell subsets at several time points after 2CBT (Table S1 ). The licensing pattern was stable at two of the time points tested ( Figure 1B ).
We subsequently focused on the NKG2A -KIR + population to determine the influence of the KIR ligand source on NK cell education. To that end, we evaluated the monoKIR-expressing NK cells' degranulation activity according to the presence or absence of the corresponding KIR-ligand in the DCB, the ndCB and/or the recipient. ( Figure 2C ). This led us to the conclusion that recipient KIR ligand played a minor role in the NK education process after 2CBT.
In 2CBT, the HLA class I environment transiently includes the ndCB HLA class I molecules. Indeed, in our cohort, whereas all patients displayed full DCB chimerism at three months after 2CBT, 8 patients underwent mixed ndCB/DCB chimerism for at least one month post-graft (See Table S1 ), thus potentially impacting licensing of the DCB. We therefore evaluated the education pattern for monoKIR + NK cells according to HLA-C-group-matched or -mismatched CB units (ie, the presence of HLA-C1 or HLA-C2 in the DCB or ndCB unit alone) at our earliest time point available, 3 months after 2CBT. The presence of KIR-ligands only in the ndCB was unable to confer responsiveness to NKG2A -monoKIR + NK cells subsets whereas the presence of KIR ligand in the DCB was associated with a significantly higher percentage of NK cell degranulation. As example, the presence of C2 ligands in the ndCB did not license monoKIR2DL1/S1 cells (Figure 3 ).
In the present study, NK-cell education was investigated 3, 6 and/or 12 months after involved in NK cell licensing. In view of the reported plasticity of the education process, the potential impact of the ndCB on this process also needed to be assessed. Indeed, in murine models, unlicensed NK cells became functional after transfer into a MHC-I-sufficient environment, whereas previously educated NK cells became hyporesponsive in an MHC-Ideficient environment 14 . However, reports on patients having undergone allo-HSCT showed the existence of a stable donor-type licensing pattern 5 as observed here, suggesting that the cell population required for NKG2A -NK cell education is transferred with the graft which will successfully reconstitute the recipient 5,15 .
In conclusion, although based on a small cohort of patients, these data provide the proof of principle governing rules of NK licensing after 2CBT with a potential impact on CB choice. Table S1 ).
SUPPLEMENTAL FILE METHODS
The present study included 20 T-cell-replete patients having undergone 2CBT at the Bone Marrow Transplantation Unit, Saint-Louis Hospital (Paris, France) between 2006 and 2012 to treat a hematological disorder (acute leukemia: n=10; aplastic anemia: n=5; non-Hodgkin lymphoma: n=3; Hodgkin disease: n=2).
Fifteen patients underwent a myeloablative conditioning regimen. The median patient age was 31.2 years (range: 14-56). Patients' HLA-C, KIR genotyping and transplant characteristics are summarized in supplemental Table 1 .
All had full, single cord blood chimerism at 3 months post-2CBT. Chimerism was determined using DNA extracted from whole blood or cord blood cells and PCR amplification of informative polymorphic microsatellite sequences and fragment analysis on an ABI 3130 XL sequencer (Applied Biosystems, Foster city, CA). Informativity was assessed in donor and recipient pre-2CBT blood samples.
All subjects provided their informed consent to participate in the study. 
Statistical analysis
The Kruskal-Wallis test was used to compare cell subsets. The threshold for statistical significance was set to P<0.05. 
